Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.47
-0.15 (-2.27%)
At close: Oct 6, 2025, 4:00 PM EDT
8.00
+1.53 (23.65%)
Pre-market: Oct 7, 2025, 6:55 AM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $349.36 million as of October 7, 2025. Its market cap has increased by 1.41% in one year.
Market Cap
349.36M
Enterprise Value
225.38M
1-Year Change
1.41%
Ranking
Category
Stock Price
$6.47
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $349.36M, an increase of 28.75%. That is a compound annual growth rate of 14.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 349.36M | 60.52% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |